The management of Carbapenem-Resistant Acinetobacter baumannii Infections with Cefiderocol

The management of Carbapenem-Resistant Acinetobacter baumannii Infections with Cefiderocol

An opportunistic bacterial pathogen called Acinetobacter baumannii and it is predominantly linked to hospital infections. This new opportunistic infection has gained substantial notoriety because of a recent rise in occurrence. It is mostly attributed to sick combat forces returning from conflict zones, combined with a sharp rise in the incidence of multidrug-resistant strains. Acinetobacter baumannii is an aerobic, pleomorphic, non-motile bacillus that is Gram-negative. Immuno compromised people are more likely to contract baumannii, especially if they have had a lengthy hospital stay of less than 90days. The fetroja price in India is determined by the National pharmaceutical pricing authority.

Here you can see about the resistant Acinetobacter baumannii Infections with Cefiderocol:

Cefiderocol pharmacology

Cefiderocol, a siderophore cephalosporin, has a conjugated catechol moiety at the 3-position side chain that enables it to chelate soluble ferric iron and then undergo active transport across gram-negative pathogens outer cell membranes. Because of this ability to use active transportation, cefiderocol can reach higher concentrations at the site of action, which leads to a relative reduction in the minimum inhibitory concentration. For buying high-quality fetroja in India, choosing the right medical shop is essential.

Clinically important lactamases that cefiderocol is stable in the presence of include serine carbapenemases, extended-spectrum lactamases, and metallo lactamases. Because of these characteristics, cefiderocol has potent in vitro activity, making it a crucial therapeutic agent for treating severely drug-resistant infections.

Cefiderocol in vitro data

Cefiderocol heteroresistance has also been reported among surveillance of carbapenem-resistant gram-negative organisms, including Acinetobacter. It may complicate the use of cefiderocol in clinical practice because heteroresistance screening is not easily integrated into routine susceptibility testing. Nevertheless, resistance has been reported following exposure to cefiderocol or other lactams among both Enterobacterales and non-fermenters. When it comes to Cefiderocol in India, you will get it at an affordable price.

Materials and methods

As a first-line and second-line treatment, cefiderocol was provided at the discretion of an infectious diseases or critical care specialist if clinically justified based on the patient’s condition and microbiological isolates. Cefiderocol was administered via a three-hour prolonged infusion that was adjusted for renal function and given in either 100 mL or 250 mL of ordinary saline, depending on the productor’s recommendation.

The remission of signs and symptoms, the resolution of respiratory failure, and clinical or laboratory evidence of improvement were all considered examples of clinical cures. Cefiderocol usage as an intravenous anti-Gram-negative agent alone or in conjunction with other active medications was classified as monotherapy and combination therapy. The median and interquartile ranges were used to describe continuous data, whereas frequencies and percentages were used to describe categorical variables.


The study comprised 14 patients who received cefiderocol treatment for severe polymicrobial pneumonia. The mean age of the patients, all men, was 61 years. 12 out of 13 patients were hospitalised with COVID-19, and 10 experienced severe respiratory failure and had to be admitted to the intensive care unit. The two individuals who were hospitalised for conditions unrelated to COVID-19 had recurrent bacterial pneumonia in one and idiopathic pulmonary fibrosis in the other.

Summing it up

Thus the above details are about the resistant Acinetobacter baumannii Infections with Cefiderocol. It is an excellent option for treating Acinetobacter baumannii infections because it will produce positive patient results.

Leave A Reply